|
1
|
Anogeianaki A, Angelucci D, Cianchetti E,
D'Alessandro M, Maccauro G, Saggini A, Salini V, Caraffa A, Tete S,
Conti F, et al: Atherosclerosis: a classic inflammatory disease.
Int J Immunopathol Pharmacol. 24:817–825. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hansson GK: Atherosclerosis - an immune
disease: the Anitschkov Lecture 2007. Atherosclerosis. 202:2–10.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Muller JE, Abela GS, Nesto RW and Tofler
GH: Triggers, acute risk factors and vulnerable plaques: the
lexicon of a new frontier. J Am Coll Cardiol. 23:809–813. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fishbein MC: The vulnerable and unstable
atherosclerotic plaque. Cardiovasc Pathol. 19:6–11. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Virmani R, Burke AP, Farb A and Kolodgie
FD: Pathology of the unstable plaque. Prog Cardiovasc Dis.
44:349–356. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartels ED, Bang CA and Nielsen LB: Early
atherosclerosis and vascular inflammation in mice with diet-induced
type 2 diabetes. Eur J Clin Invest. 39:190–199. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Massova I, Kotra LP, Fridman R and
Mobashery S: Matrix metalloproteinases: structures, evolution, and
diversification. FASEB J. 12:1075–1095. 1998.PubMed/NCBI
|
|
8
|
Orbe J, Fernandez L, Rodríguez JA, Rábago
G, Belzunce M, Monasterio A, Roncal C and Páramo JA: Different
expression of MMPs/TIMP-1 in human atherosclerotic lesions.
Relation to plaque features and vascular bed. Atherosclerosis.
170:269–276. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fiotti N, Altamura N, Orlando C, Simi L,
Reimers B, Pascotto P, Zingone B, Pascotto A, Serio M, Guarnieri G,
et al: Metalloproteinases-2, −9 and TIMP-1 expression in stable and
unstable coronary plaques undergoing PCI. Int J Cardiol.
127:350–357. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bot PT, Grundmann S, Goumans M-J, de
Kleijn D, Moll F, de Boer O, van der Wal AC, van Soest A, de Vries
JP, van Royen N, et al: Forkhead box protein P1 as a downstream
target of transforming growth factor-β induces collagen synthesis
and correlates with a more stable plaque phenotype.
Atherosclerosis. 218:33–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deng H-B, Jiang CQ, Tomlinson B, Liu B,
Lin JM, Wong KS, Cheung BM, Lam TH and Thomas GN: A polymorphism in
transforming growth factor-β1 is associated with carotid plaques
and increased carotid intima-media thickness in older Chinese men:
the Guangzhou Biobank Cohort Study-Cardiovascular Disease
Subcohort. Atherosclerosis. 214:391–396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Walton CB, Anderson CD, Boulay R and
Shohet RV: Introduction to the ultrasound targeted microbubble
destruction technique. J Vis Exp. 12:29632011.
|
|
13
|
Fujii H, Li S-H, Wu J, Miyagi Y, Yau TM,
Rakowski H, Egashira K, Guo J, Weisel RD and Li R-K: Repeated and
targeted transfer of angiogenic plasmids into the infarcted rat
heart via ultrasound targeted microbubble destruction enhances
cardiac repair. Eur Heart J. 32:2075–2084. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li HL, Zheng XZ, Wang HP, Li F, Wu Y and
Du LF: Ultrasound-targeted microbubble destruction enhances
AAV-mediated gene transfection in human RPE cells in vitro and rat
retina in vivo. Gene Ther. 16:1146–1153. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng X, Du L, Wang H and Gu Q: A novel
approach to attenuate proliferative vitreoretinopathy using
ultrasound-targeted microbubble destruction and recombinant
adeno-associated virus-mediated RNA interference targeting
transforming growth factor-β2 and platelet-derived growth factor-B.
J Gene Med. 14:339–347. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Padda RS, Gkouvatsos K, Guido M, Mui J,
Vali H and Pantopoulos K: A high-fat diet modulates iron metabolism
but does not promote liver fibrosis in hemochromatotic
Hjv−/− mice. Am J Physiol Gastrointest Liver Physiol.
308:G251–G261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Daya S and Berns KI: Gene therapy using
adeno-associated virus vectors. Clin Microbiol Rev. 21:583–593.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Howard CM, Forsberg F, Minimo C, Liu JB,
Merton DA and Claudio PP: Ultrasound guided site specific gene
delivery system using adenoviral vectors and commercial ultrasound
contrast agents. J Cell Physiol. 209:413–421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mallat Z, Gojova A, Marchiol-Fournigault
C, Esposito B, Kamaté C, Merval R, Fradelizi D and Tedgui A:
Inhibition of transforming growth factor-β signaling accelerates
atherosclerosis and induces an unstable plaque phenotype in mice.
Circ Res. 89:930–934. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rouis M, Adamy C, Duverger N, Lesnik P,
Horellou P, Moreau M, Emmanuel F, Caillaud JM, Laplaud PM, Dachet
C, et al: Adenovirus-mediated overexpression of tissue inhibitor of
metalloproteinase-1 reduces atherosclerotic lesions in
apolipoprotein E-deficient mice. Circulation. 100:533–540. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guevara NV, Chen K-H and Chan L: Apoptosis
in atherosclerosis: pathological and pharmacological implications.
Pharmacol Res. 44:59–71. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cagnol S and Chambard JC: ERK and cell
death: Mechanisms of ERK-induced cell death - apoptosis, autophagy
and senescence. FEBS J. 277:2–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Khwaja A: Akt is more than just a Bad
kinase. Nature. 401:33–34. 1999. View
Article : Google Scholar : PubMed/NCBI
|
